Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.12.19
Views: 146

Prof Deborah Fenlon - Swansea University, Swansea, UK

Prof Deborah Fenlon talks to ecancer about a study reviewing laser therapy for vulvo-vaginal atrophy (VVA) or genito-urinary syndrome of menopause (GSM) in breast cancer survivors.

She explains that when women undergo the menopause they can develop VVA which can leave them vulnerable to vaginal and urinary tract infections.

As chemotherapy and other therapies can knock out the ovaries, this can lead to an early menopause and therefore leave cancer survivors subject to infections.

Prof Fenlon explains that the laser treatment removes very fine layers of skin from the vagina, stimulating new growth and helping it become healthier.

Related videos

follow us

WIN 2020

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation